Figure EYE-2 part (i): Changes 1995-2003 in lifetime prevalence (percentage) of ecstasy use among 15 to 16 year old school students
Notes:
In Bulgaria, France, Greece and Romania increases are since 1999 due to lack of data for 1995.
For the Netherlands, and the 1999 survey and the increase since 1999 are not strictly comparable with ESPAD.
Spain did not participate in the ESPAD survey. The data included here is based on a Spanish survey conducted November-December 2002.
Drug prevalence questions may be considered comparable to the ESPAD questions but other aspects of the method mean that the Spanish data are not strictly comparable.
Source:
Hibell et al., 2004